PlasmaGen Biosciences raises Rs 150 crore, valued at Rs 1,500 crore, led by ViNS Bioproducts to expand its international operations and product portfolio.
Amount Raised
₹1.5 Billion
Round Type
Funding Round
Investors
Description
PlasmaGen Biosciences has secured Rs 150 crore in funding led by ViNS Bioproducts, with support from family offices and pharmaceutical entrepreneurs. The Bengaluru startup is focused on scaling international operations and expanding its product range. Founded in 2010, PlasmaGen specializes in blood plasma-derived therapies. This funding round reflects growing confidence in the company's long-term vision.
Quick answer
PlasmaGen Biosciences raised ₹1.5 Billion in a Funding Round round, dated December 22, 2025. Investors: ViNS Bioproducts.
- How much did PlasmaGen Biosciences raise?
- PlasmaGen Biosciences raised ₹1.5 Billion in a Funding Round round on December 22, 2025.
- Who invested in PlasmaGen Biosciences?
- ViNS Bioproducts is named as investors in this round.
- What does PlasmaGen Biosciences do?
- PlasmaGen BioSciences Private Limited is India’s first company dedicated to Plasma Protein Therapeutics, founded in 2010 and headquartered in Bengaluru.
- Where is PlasmaGen Biosciences based and how big is it?
- Fundz records about 420 employees.
- Who are the decision-makers at PlasmaGen Biosciences?
- Fundz holds 1 contact at PlasmaGen Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical Manufacturing and pharmaceuticals around the same time
Companies in the same sectors as PlasmaGen Biosciences that raised within 45 days of this round, from Fundz verified event records.
- NuVision Biotherapies raised $6.6M on February 5, 2026.
- Ecovia Renewables raised an undisclosed amount (Series B) on February 3, 2026.
- Visolis raised $2.9M (Grant) on January 29, 2026.
- Cellares raised $257M (Series D) on January 28, 2026.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- Nami Surgical raised $2.6M (Seed) on January 28, 2026.
Who to call at PlasmaGen Biosciences, and when
A new round usually means PlasmaGen Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PlasmaGen Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PlasmaGen Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PlasmaGen Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PlasmaGen Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PlasmaGen Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.